伤口世界
  • 首页
  • 病情图文
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
      • 动脉性溃疡
      • 静脉性溃疡
      • 放射性溃疡
    • 烧伤
    • 创伤
    • 少见伤口
    • 祛疤止痒
    • 皮肤病
  • 医师讲座
  • 名医介绍
    专业服务
    • 糖尿病足
    • 压疮
    • 造口
    • 溃疡
    • 烧伤
    蔡道章院长

    Custom Mod Mega1

    主任医师、教授、博导,南方医科大学第三附属医院(广东省骨科医院)院长

    • 中德骨科伤口管理学校校长
    • 广东省骨科研究院运动医学研究所所长
    • 广东省内运动医学专业唯一的博士研究生导师
    • 美国哈弗大学医学院骨科访问学者
    • 专业特长处于省内领先、国内或国际先进水平以上
    • 2018年获得“国之名医卓越建树”荣誉称号
    • 2017年被评为全国卫生计生系统先进工作者、广东省医学领军人才
    • 中国医师协会运动医师分会副会长
    • STCOT中国部运动医学分会副主任委员
    • 广东省医学会关节外科分会主任委员
    • 广东省医学会运动医学会分会名誉主任委员
    • 独立承担过国家“863”课题,主持过10余项省、部级科研项目
    • 多份专业杂志编委
  • 文献精选
    伤口分类
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
    • 烧伤
    • 更多关于伤口信息
    最新文献
    • Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial 2026-07-28 00:00

      Azadeh Dorostkar1 , Mehdi Ghahartars1 , Mohammadreza Namazi1 , Nafiseh Todarbary2 , Maryam Hadibarhaghtalab1 , Maryam Rezaee1

      1 Dermatology Department, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

      2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

      Key words: topical, sodium hypochlorite, acne vulgaris, treatment

      Citation: Dorostkar A, Ghahartars M, Namazi M, Todarbary N, Hadibarhaghtalab M, Rezaee M. Sodium hypochlorite 0.005%

      versus placebo in the treatment of mild to moderate acne: a double-blind randomized controlled trial. Dermatol Pract Concept.

      2021;11(3):e2021046. DOI: https://doi.org/10.5826/dpc.1103a46

      Accepted: December 9, 2020; Published: May 20, 2021

      Copyright: ©2021 Dorostkar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License

      BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors

      and source are credited.

      Competing interests: The authors have no conflicts of interest to declare.

      Funding: None

      Corresponding author: Maryam Hadibarhaghtalab, Department of Dermatology, Faghihi Hospital, Zand Street, Shiraz, Iran.

      Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

      ABSTRACT  

      Background: Acne vulgaris is a common inflammatory disease of the pilosebaceous follicle that affects many teenagers and young people. There is an obvious need for topical treatments with good tolerability and efficacy for the management of acne lesions.

      Objective: This study determined the therapeutic efficacy of topical sodium hypochlorite solution (0.005%) in the treatment of mild to moderate acne lesions.

      Methods: This placebo-controlled randomized controlled trial compared 0.005% sodium hypochlorite to placebo administered topically on each side of the patients’ faces 3 times a day for 1 month. The numbers of papules and pustules were recorded at baseline, 1, 2 and 4 weeks after initiation.

      Results: The total number of papules and pustules decreased after topical application of sodium hypochlorite 0.005% for 1 month.

      Conclusions: Topical sodium hypochlorite solution (0.005%) can be effective in the treatment of mild to moderate acne, and its clinical efficacy was evaluated between the male and female groups and between the hormonal and non-hormonal ones.

      Trial registration: Our study was registered in the Iranian Registry of Clinical Trials (IRCT) with the code number IRCT20200701047976N1.

    • Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial 2026-07-28 00:00

      Azadeh Dorostkar1 , Mehdi Ghahartars1 , Mohammadreza Namazi1 , Nafiseh Todarbary2 , Maryam Hadibarhaghtalab1 , Maryam Rezaee1

      1 Dermatology Department, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

      2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

      Key words: topical, sodium hypochlorite, acne vulgaris, treatment

      Citation: Dorostkar A, Ghahartars M, Namazi M, Todarbary N, Hadibarhaghtalab M, Rezaee M. Sodium hypochlorite 0.005%

      versus placebo in the treatment of mild to moderate acne: a double-blind randomized controlled trial. Dermatol Pract Concept.

      2021;11(3):e2021046. DOI: https://doi.org/10.5826/dpc.1103a46

      Accepted: December 9, 2020; Published: May 20, 2021

      Copyright: ©2021 Dorostkar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License

      BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors

      and source are credited.

      Competing interests: The authors have no conflicts of interest to declare.

      Funding: None

      Corresponding author: Maryam Hadibarhaghtalab, Department of Dermatology, Faghihi Hospital, Zand Street, Shiraz, Iran.

      Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

      ABSTRACT  

      Background: Acne vulgaris is a common inflammatory disease of the pilosebaceous follicle that affects many teenagers and young people. There is an obvious need for topical treatments with good tolerability and efficacy for the management of acne lesions.

      Objective: This study determined the therapeutic efficacy of topical sodium hypochlorite solution (0.005%) in the treatment of mild to moderate acne lesions.

      Methods: This placebo-controlled randomized controlled trial compared 0.005% sodium hypochlorite to placebo administered topically on each side of the patients’ faces 3 times a day for 1 month. The numbers of papules and pustules were recorded at baseline, 1, 2 and 4 weeks after initiation.

      Results: The total number of papules and pustules decreased after topical application of sodium hypochlorite 0.005% for 1 month.

      Conclusions: Topical sodium hypochlorite solution (0.005%) can be effective in the treatment of mild to moderate acne, and its clinical efficacy was evaluated between the male and female groups and between the hormonal and non-hormonal ones.

      Trial registration: Our study was registered in the Iranian Registry of Clinical Trials (IRCT) with the code number IRCT20200701047976N1.

  • 互动快递
  • 首页
  • 病情图文
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
      • 动脉性溃疡
      • 静脉性溃疡
      • 放射性溃疡
    • 烧伤
    • 创伤
    • 少见伤口
    • 祛疤止痒
    • 皮肤病
  • 医师讲座
  • 名医介绍
    • 专业服务
      • 糖尿病足
      • 压疮
      • 造口
      • 溃疡
      • 烧伤
    • 蔡道章院长
  • 文献精选
    • 伤口分类
      • 糖尿病足
      • 压疮
      • 感染伤口
      • 造口
      • 溃疡
      • 烧伤
      • 更多关于伤口信息
    • 最新文献
  • 互动快递
  • 当前位置: 
  • 首页
  • 文献精选

文献精选

CASIN exerts anti-aging effects through RPL4 on the skin of  naturally aging mice

CASIN exerts anti-aging effects through RPL4 on the skin of naturally aging mice

伤口世界,
2025-09-19 00:00
发布于 文献精选
1022 Views
0 Comment

Protective, Anti-Inflammatory, and Anti-Aging Effects of Soy Isoflavones on Skin Cells: An Overview of In Vitro and In Vivo Studies

Protective, Anti-Inflammatory, and Anti-Aging Effects of Soy Isoflavones on Skin Cells: An Overview of In Vitro and In Vivo Studies

伤口世界,
2025-09-18 00:00
发布于 文献精选
1140 Views
0 Comment

Alternative Splicing: Emerging Roles in Anti-Aging Strategies

Alternative Splicing: Emerging Roles in Anti-Aging Strategies

伤口世界,
2025-09-17 00:00
发布于 文献精选
1038 Views
0 Comment

Exploring Anti-Aging Effects of Topical Treatments for Actinic Keratosis

Exploring Anti-Aging Effects of Topical Treatments for Actinic Keratosis

伤口世界,
2025-09-16 00:00
发布于 文献精选
1394 Views
0 Comment

  • 首页
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 末页
第48页 共487页

Categories

  • 病情图文
  • 文献精选
  • 名医介绍
  • K2 Content
  • Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial 2026-07-28 00:00

    Azadeh Dorostkar1 , Mehdi Ghahartars1 , Mohammadreza Namazi1 , Nafiseh Todarbary2 , Maryam Hadibarhaghtalab1 , Maryam Rezaee1

    1 Dermatology Department, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

    Key words: topical, sodium hypochlorite, acne vulgaris, treatment

    Citation: Dorostkar A, Ghahartars M, Namazi M, Todarbary N, Hadibarhaghtalab M, Rezaee M. Sodium hypochlorite 0.005%

    versus placebo in the treatment of mild to moderate acne: a double-blind randomized controlled trial. Dermatol Pract Concept.

    2021;11(3):e2021046. DOI: https://doi.org/10.5826/dpc.1103a46

    Accepted: December 9, 2020; Published: May 20, 2021

    Copyright: ©2021 Dorostkar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License

    BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors

    and source are credited.

    Competing interests: The authors have no conflicts of interest to declare.

    Funding: None

    Corresponding author: Maryam Hadibarhaghtalab, Department of Dermatology, Faghihi Hospital, Zand Street, Shiraz, Iran.

    Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

    ABSTRACT  

    Background: Acne vulgaris is a common inflammatory disease of the pilosebaceous follicle that affects many teenagers and young people. There is an obvious need for topical treatments with good tolerability and efficacy for the management of acne lesions.

    Objective: This study determined the therapeutic efficacy of topical sodium hypochlorite solution (0.005%) in the treatment of mild to moderate acne lesions.

    Methods: This placebo-controlled randomized controlled trial compared 0.005% sodium hypochlorite to placebo administered topically on each side of the patients’ faces 3 times a day for 1 month. The numbers of papules and pustules were recorded at baseline, 1, 2 and 4 weeks after initiation.

    Results: The total number of papules and pustules decreased after topical application of sodium hypochlorite 0.005% for 1 month.

    Conclusions: Topical sodium hypochlorite solution (0.005%) can be effective in the treatment of mild to moderate acne, and its clinical efficacy was evaluated between the male and female groups and between the hormonal and non-hormonal ones.

    Trial registration: Our study was registered in the Iranian Registry of Clinical Trials (IRCT) with the code number IRCT20200701047976N1.

  • Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial 2026-07-28 00:00

    Azadeh Dorostkar1 , Mehdi Ghahartars1 , Mohammadreza Namazi1 , Nafiseh Todarbary2 , Maryam Hadibarhaghtalab1 , Maryam Rezaee1

    1 Dermatology Department, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

    Key words: topical, sodium hypochlorite, acne vulgaris, treatment

    Citation: Dorostkar A, Ghahartars M, Namazi M, Todarbary N, Hadibarhaghtalab M, Rezaee M. Sodium hypochlorite 0.005%

    versus placebo in the treatment of mild to moderate acne: a double-blind randomized controlled trial. Dermatol Pract Concept.

    2021;11(3):e2021046. DOI: https://doi.org/10.5826/dpc.1103a46

    Accepted: December 9, 2020; Published: May 20, 2021

    Copyright: ©2021 Dorostkar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License

    BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors

    and source are credited.

    Competing interests: The authors have no conflicts of interest to declare.

    Funding: None

    Corresponding author: Maryam Hadibarhaghtalab, Department of Dermatology, Faghihi Hospital, Zand Street, Shiraz, Iran.

    Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

    ABSTRACT  

    Background: Acne vulgaris is a common inflammatory disease of the pilosebaceous follicle that affects many teenagers and young people. There is an obvious need for topical treatments with good tolerability and efficacy for the management of acne lesions.

    Objective: This study determined the therapeutic efficacy of topical sodium hypochlorite solution (0.005%) in the treatment of mild to moderate acne lesions.

    Methods: This placebo-controlled randomized controlled trial compared 0.005% sodium hypochlorite to placebo administered topically on each side of the patients’ faces 3 times a day for 1 month. The numbers of papules and pustules were recorded at baseline, 1, 2 and 4 weeks after initiation.

    Results: The total number of papules and pustules decreased after topical application of sodium hypochlorite 0.005% for 1 month.

    Conclusions: Topical sodium hypochlorite solution (0.005%) can be effective in the treatment of mild to moderate acne, and its clinical efficacy was evaluated between the male and female groups and between the hormonal and non-hormonal ones.

    Trial registration: Our study was registered in the Iranian Registry of Clinical Trials (IRCT) with the code number IRCT20200701047976N1.

  • Micropore drainage to prevent hematoma in axillary bromhidrosis A comparative study 2026-07-27 00:00

    Jiao-Jiao Yang, MBBSa , Jie-Ling Bai, MBBSa , Shuai Qiang, PhDb, Yong Ma, MBBSc, *

    Abstract

    Axillary bromhidrosis is characterized by malodor stemming from hyperplastic and hypertrophic apocrine sweat glands. Although surgical excision remains the most definitive treatment, postoperative complications—particularly hematoma—can compromise outcomes and patient satisfaction. This study evaluated the effectiveness of a micropore drainage technique in reducing hematoma and improving overall results. This retrospective comparative study analyzed data from medical records of 73 patients diagnosed with axillary bromhidrosis who underwent surgical treatment at the 3201 Hospital in Hanzhong, China, from January 2020 to January 2024. Patients had initially been randomized into either the experimental group (group A, n = 38), which received micropore drainage combined with subdermal undermining via a miniature incision, or the control group (group B, n = 35), treated by subdermal undermining alone. Inclusion and exclusion criteria were strictly followed during retrospective selection. Outcomes, evaluated by blinded assessors, included malodor elimination, Dermatology Life Quality Index (DLQI) scores, hair growth reduction, scar formation, postoperative complications, and patient satisfaction. Both groups achieved significant improvements in malodor control and DLQI scores. Notably, the hematoma rate was 0% in Group A compared to 11.43% in Group B (P = .02). Group A also demonstrated higher patient satisfaction (81.58% vs 51.43%, P = .01). There were no significant differences between the groups in operative time, scar formation, DLQI improvement, or hair growth reduction. Incorporating micropore drainage into surgical management of axillary bromhidrosis effectively reduces postoperative hematoma and enhances patient satisfaction without increasing operative complexity or compromising apocrine gland removal. This technique shows promise as a safer, more reliable option for axillary bromhidrosis treatment, warranting further validation through larger multicenter studies and longer-term follow-up.

    Abbreviations: AB = axillary bromhidrosis, DLQI = Dermatology Life Quality Index.

    Keywords: apocrine glands, axillary bromhidrosis, Dermatology Life Quality Index, hematoma, micropore drainage, seroma, surgical treatment

Popular Tags

  • 糖尿病足
  • 溃疡
  • 动脉性溃疡
  • 静脉性溃疡
  • 放射性溃疡
  • 烧伤
  • 创伤
  • 祛疤止痒
  • 皮肤病
  • 造口

伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。

 

消息订阅

关注伤口世界动态,了解专业领域最新科技
Copyright © 2026 中诺医疗. All Rights Reserved
粤ICP备20066836号

学术会议

2019广东省医疗行业协会伤口管理分会年会

扫一扫了解详情:

 

  • 2019年6月15日 中国广州
  • 主办单位:广东省医疗行业协会伤口管理分会

伤口世界提示

任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。

网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。